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Abstract: The purpose of this paper is to evaluate the feasibility of diagnosing multiple sclerosis
(MS) using optical coherence tomography (OCT) data and a support vector machine (SVM) as an
automatic classifier. Forty-eight MS patients without symptoms of optic neuritis and forty-eight
healthy control subjects were selected. Swept-source optical coherence tomography (SS-OCT) was
performed using a DRI (deep-range imaging) Triton OCT device (Topcon Corp., Tokyo, Japan). Mean
values (right and left eye) for macular thickness (retinal and choroidal layers) and peripapillary area
(retinal nerve fibre layer, retinal, ganglion cell layer—GCL, and choroidal layers) were compared
between both groups. Based on the analysis of the area under the receiver operator characteristic
curve (AUC), the 3 variables with the greatest discriminant capacity were selected to form the feature
vector. A SVM was used as an automatic classifier, obtaining the confusion matrix using leave-one-out
cross-validation. Classification performance was assessed with Matthew’s correlation coefficient
(MCC) and the AUCCLASSIFIER. The most discriminant variables were found to be the total GCL++
thickness (between inner limiting membrane to inner nuclear layer boundaries), evaluated in the
peripapillary area and macular retina thickness in the nasal quadrant of the outer and inner rings.
Using the SVM classifier, we obtained the following values: MCC = 0.81, sensitivity = 0.89, specificity
= 0.92, accuracy = 0.91, and AUCCLASSIFIER = 0.97. Our findings suggest that it is possible to classify
control subjects and MS patients without previous optic neuritis by applying machine-learning
techniques to study the structural neurodegeneration in the retina.
Keywords: multiple sclerosis; optical coherence tomography; support vector machine; confusion
matrix
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1. Introduction
Multiple sclerosis (MS) causes inflammation, demyelination, axonal degeneration, and neuronal
loss in the central nervous system (CNS), hindering axonal conduction and provoking progressive
clinical disability in patients.
A single biomarker for diagnosing MS does not exist at present. Oligoclonal bands, magnetic
resonance imaging (MRI), and optical coherence tomography (OCT) are all used in clinical practice [1].
MRI is one of the clinical tests that is most widely used in the diagnosis of MS [2]. However, the lesions
shown in the images only explain a small fraction of the patient’s clinical symptoms (known as the
clinico-radiological paradox). It is, therefore, highly worthwhile to seek new biomarkers capable of
determining diagnosis of the disease.
The visual system is an extension of the central nervous system and the neurodegenerative
processes of MS frequently manifest in visual pathways [3], making the analysis of them a means of
diagnosing the disease and evaluating its progress. OCT uses low-coherence interferometry to produce
a two-dimensional image of optical scattering from internal tissue microstructures [4], making it
possible to obtain valid information with which to assess the anatomical integrity of the optic nerve and
retina. OCT detects the depth at which a difference is present in the refractive index in the transition
from one tissue to another. OCT is a rapid (2–3 min) [5], innocuous, cost-effective, and non-invasive
test that does not require technical specialization from the practitioner.
The first generation of OCT devices worked in the time domain (time domain OCT:TD-OCT)
and depth profiles were acquired by scanning the length of the reference arm to map out the
tissue reflectivity [6]. The next-generation technology obtains reflectivity values by taking separate
measurements in the Fourier domain for a multitude of wavelengths (Fourier domain OCT:FD-OCT).
On a practical level, this is implemented using either a spectrometer and a line scan camera (spectral
domain OCT:SD-OCT) or a tuneable swept laser as the light source and a single photodiode detector
(swept source OCT:SS-OCT) [6]. This hardware simplification in SS-OCT enables fast scanning speeds
of up to 400,000 axial scans per second in non-commercial prototypes [7]. The A-scan speed in
commercial SS-OCT devices is 100,000 Hz [8], providing more accurate three-dimensional images
of the retina and even the choroid, yielding 8 and 20 µm axial and transverse resolutions in tissue,
respectively [9,10]. In non-commercial systems, axial and transverse resolutions of 2 µm over a field of
view of 1 × 1 mm2 [11] are obtained.
All these characteristics have meant that OCT has revolutionized daily clinical practice in
neuro-ophthalmology, because the technique makes it possible to quantify, non-invasively, rapidly,
objectively, reliably, and highly reproducibly [12], the major pathological hallmarks of the disease,
specifically, inflammation and neuroaxonal degeneration [13]. It also uses the same anatomical area in
the follow-up examinations of the eye, which makes it possible to monitor neurological deterioration
in neurodegenerative pathologies, thereby serving as a reliable progression biomarker. Some authors
consider its reliability to be as high or higher than serial MRI (a test that it is neither innocuous nor
cheap, unlike OCT) [14].
The first study using OCT in MS patients was conducted in [15], observing a significant reduction in
the retinal nerve fibre layer (RNFL) of patients with MS and previous optic neuritis (ON) when compared
with control subjects. Many subsequent studies have confirmed these findings in patients with and
without ON, even providing confirmation before clinical symptoms have been presented [16–20].
Two meta-analyses include the latest advances in application of OCT in diagnosis of MS. In the
work of Britze et al. [21], it was documented that the thickness of the ganglion cell layer (GCL) was
significantly reduced in MS patients both with and without previous ON compared to healthy control
subjects. In this meta-analysis (involving a study of 2118 eyes), a reduction in the combined GCL
and IPL (inner plexiform layer, together referred to as GCIPL) layers of 6.73 µm was estimated in MS
patients without ON. The meta-analysis by Petzold et al. [19] spans 15 studies of retinal thicknesses
measured with SD-OCT (conducted in patients without ON, obtaining an estimated peripapillary
thickness loss in MS patients and finding that the peripapillary RNFL and macular GCIPL are the most
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affected layers). In a recent paper [22] studying 97 MS patients without ON episodes, the authors also
found, in this case, using SS-OCT, a thinning of retinal thickness in the macular and peripapillary areas
in the RNFL and GCL.
Previous studies demonstrate that analysing retinal layers with the latest OCT technology is
useful for distinguishing between MS patients and control subjects. None of the papers, however,
have employed machine-learning techniques. In this article, the authors go one step further and use
machine-learning to optimize the diagnostic capability of the OCT variables and give the technique
real clinical applicability, for any population, due to the aforementioned self-learning capabilities.
Machine-learning approaches have been investigated in MS diagnosis. Among these (linear
discriminant analysis, random forest, neural networks, etc.), support vector machines (SVM) have
demonstrated their effectiveness.
In a classifier, the SVM algorithm maximizes the margin that separates different classes of data.
In [23], a SVM acted as a classifier of functional and diffusion MRI data for characterization of
relapsing-remitting multiple sclerosis (RRMS) patients. In [24], a SVM was used to predict the course
of MS, with demographic and clinical characteristics, MRI features, and characteristics of the first
symptom(s) of MS being used as classifier inputs. Zhang et al. [25] diagnosed MS versus controls,
comparing three machine-learning-based classifiers, namely, the decision tree, the nearest-neighbour
classifier, and the support vector machine.
The objective of this paper is to use machine-learning techniques (a support vector machine) to
classify variables obtained with OCT in order to differentiate between control subjects and MS patients.
As shown in the general diagram in Figure 1, data were obtained from each patient using an SS-OCT
system. In the feature selection stage, the OCT variables with greatest discriminant capacity, evaluated
using the area under the receiver operating characteristic (ROC) curve, were selected and used in a
classifier implemented in a SVM to obtain the diagnosis.
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of the annual visits, were excluded. Active MS flare was considered a reason for exclusion because 
acute axonal loss could mask neuronal damage secondary to MS progression (i.e., chronic 
neurodegeneration), which was the main purpose of this study. Patient disability was analysed 
using the Expanded Disability Status Scale (EDSS), and the treatment received by each patient was 
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Figure 1. General block diagram. OCT: Optical coherence tomography. SS-OCT: Swept-source OCT;
ETDRS: Early treatment diabetic retinopathy study; GCL++_Total: Global GCL++ thickness, evaluated
at the peripapillary area between the inner limiting membrane and the inner nuclear layer boundaries;
ETDRS_IN_Retina: Macular retina thickness in the nasal quadrant of the inner ring; ETDRS_ON_Retina:
Macular retina thickness in the nasal quadrant of the outer ring; SVM: Support vector machine.
2. Materials and Methods
The study procedures were performed in accordance with the tenets of the Declaration of Helsinki,
and the study protocol was approved by the local ethics committees (Clinical Research Ethics Committee
of Aragon—CEICA, Zaragoza, Spain). Written informed consent to participate in the study was
obtained from all subjects.
Relapsing-remitting MS was diagnosed based on the 2010 revision of the McDonald criteria [26]
and was confirmed by a neurologist specializing in MS. Patients with visual acuity less than 0.6
(Snellen scale), intraocular pressure >20 mmHg, a history of optic neuritis, and/or an active MS flare
(of any neurological deficit) in the past 6 months preceding their enrolment into the study, or at
any of the annual visits, were excluded. Active MS flare was considered a reason for exclusion
because acute axonal loss could mask neuronal damage secondary to MS progression (i.e., chronic
neurodegeneration), which was the main purpose of this study. Patient disability was analysed using
the Expanded Disability Status Scale (EDSS), and the treatment received by each patient was considered.
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Axial length was assessed in all individuals. Eyes longer than 25.2 mm and refractive errors
≥5 dioptres (D) of equivalent spherical diameter or ≥3 D of astigmatism were excluded from the study.
The participants (MS patients and healthy control subjects) had no concomitant ocular diseases, nor
any previous history of retinal pathology, glaucoma, amblyopia, or systemic conditions that could
affect the visual system.
Retinal atrophy after acute ON is often more pronounced than the retinal thinning observed in the
absence of ON in MS [19]. For this reason, eyes with previous ON were excluded from the analysis.
A complete neuro-ophthalmic examination, including assessment of best-corrected visual acuity
using the Snellen chart, contrast sensitivity vision (CSV) using the CSV1000 test, colour vision using
the Ishihara test, pupillary reflexes, ocular motility, examinations of the anterior segment, intraocular
pressure measurement using the Goldmann applanation tonometer, and papillary morphology, by a
fundoscopic exam, was performed on all subjects in order to detect any ocular alteration (such as
primary open-angle glaucoma, prior optic neuritis, cataracts, or corneal pathology) that could affect
the optic nerve or neuro-retinal structure.
2.1. OCT Method
The 3D wide protocol was used for all subjects. This protocol includes a wide scanning range (9 mm
high × 12 mm wide) that focuses on both the macula (ETDRS: Early treatment diabetic retinopathy
study scan) and the peripapillary area (TSNIT: Temporal-superior-nasal-inferior-temporal scan).
With the ETDRS scan (Figure 2), nine macular areas [21] (which include a central 1-mm circle
representing the fovea, and inner and outer rings measuring 3 mm and 6 mm in diameter, respectively,
the latter two divided into quadrants by two intersecting lines), central and average thickness, plus
macular volume were obtained. The nine areas are denominated as follows: central fovea (CF), inner
superior (IS), inner nasal (IN), inner inferior (II), inner temporal (IT), outer superior (OS), outer nasal
(ON), outer inferior (OI) and outer temporal (OT).
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The diameter of the peripapillary area measured in the TSNIT scan was 3.40 mm. The TSNIT
provides measurements of the 4 peripapillary quadrants (superior, nasal, inferior and temporal) and
6 sectors (superonasal, superotemporal, nasal, temporal, inferonasal and inferotemporal, Figure 2).
The ETDRS and TSNIT scans provide separate, automated measurements of different retinal
layers, specifically: RNFL (between the inner limiting membrane—ILM and the GCL boundaries),
GCL+ (between the RNFL and the inner nuclear layer boundaries), GCL++ (between the ILM and
the inner nuclear layer boundaries), and retinal thickness (between the ILM and the retinal pigment
epithelium boundaries). Additionally, both the ETDRS and TSNIT protocols provide automated
choroidal thickness measurements (from the Bruch membrane to the choroidal-scleral interface).
In this study, the authors recorded the total retinal and choroid thickness in the 9 ETDRS macular
areas and the RNFL, retina, GCL+, GCL++, and choroid thickness in the 4 quadrants and 6 sectors of
the TSNIT peripapillary area.
All scans were obtained by the same experienced operator and were checked by an experienced
rater for segmentation quality immediately after acquisition. If erroneous segmentation was observed,
the scan was rejected and repeated. The DRI Triton SS-OCT (1050 nm) provides a quality scale in the
image to indicate the signal strength. The quality score ranges from 0 (poor quality) to 100 (excellent
quality). Only images with a score >55 were analysed in our study. Poor-quality images were rejected
and recaptured prior to data analysis.
In the first phase of the work, the authors obtained the area under the receiver operator characteristic
curve (AUC), as to evaluate the discriminant capacity of each of the available variables. Next, the
variables with the highest AUC were selected as components of the classifier’s input feature vector.
2.2. Support Vector Machine
In a two-class classification problem, a SVM seeks the hyperplane that separates two different
classes with maximum margins (support vectors) [27]. If the original data (X) are not linearly separable,
a non-linear transformation to a higher dimensional space (H) can be performed using a kernel function,
Φ(.) := X→ H, such that H improves the separability between the two classes. Kernel function
examples include linear, polynomial, radial basis, or Gaussian, etc.
In this paper, the Gaussian function below was used as the transformation kernel.
KGaussian(x, c) = exp
(
−‖x− c‖2/2.σ2
)
(1)
where x, c ∈ RP, c is the centre of the Gaussian function, and P is the dimension of the feature vector.
The σ parameter determines the width of the Gaussian kernel.
2.3. Statistical Methods and Classification Assessment
Statistical analyses were performed with the IBM SPSS Statistics 25 software package (IBM Corp.,
Armonk, NY, USA) and Statgraphics Centurion XVII (Statpoint Technologies Inc., Warrenton, VA,
USA). To eliminate possible confusion factors associated with age, exhaustive comparisons were made
between the control subjects and the MS patients, analysing the distribution, central trend (means and
medians), and variance. A similar comparison was made with the rest of the OCT variables analysed
in the study. The comparisons between groups were analysed as follows: Kolmogorov–Smirnov (K–S)
tests were used to test distributions, Fisher–Snedecor distribution was used to study the differences in
variances, Student’s t distribution was used to analyse the means, and the Mann–Whitney Wilcoxon
test was used to compare the medians.
The K–S non-parametric test determines if two samples of data are from the same distribution.
The Fisher–Snedecor distribution is a parametric approach to study the equality of the variances of the
samples. The analysis of means was performed with the parametric Student’s t test, and the medians
were analysed using the Mann–Whitney Wilcoxon non-parametric test. The parametric tests were
conducted under normal conditions in the groups.
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A p value < 0.05 was considered statistically significant. Correlations were estimated with
the Pearson rank correlation. The area under the ROC curve (calculated with SPSS Statistics 25)
was employed to assess the discrimination capability of the feature proposed in this study. The
AUC quantifies the overlaps between variables distributions. An AUC value of 0.5 implies that the
distributions in controls and patients groups overlap. AUC values above 0.9 indicate high diagnostic
accuracy [28].
The classifier was implemented using the Classification Learner app included in Statistics and
Machine Learning Toolbox 11.6 from MATLAB (Mathworks Inc., Natick, MA, USA). Classification
performance was assessed using Matthew’s correlation coefficient (MCC), which summarizes the
confusion matrix [29]. MCC ranges are between 1 and –1. A MCC value of 1 denotes a perfect
classification, while a value of –1 is a totally erroneous classification, and 0 indicates a random prediction.
In a binary classification problem, the MCC is recommended over other parameters like the accuracy
and F1 score [30]. The performance of the classifier was evaluated using leave-one-out cross-validation.
3. Results
Table 1 shows the results of comparison of the ages of the subjects in the sample. It the
compares distributions (Kolmogorov–Smirnov statistic), variances (Fisher–Snedecor distribution),
means (Student’s t test) and medians (Mann–Whitney Wilcoxon). The sample can be considered
homogeneous in terms of age, as the comparisons made do not reveal any significant differences
(p > 0.05). Although there were no differences between groups, there was a larger proportion of females
due to the greater incidence of this disease in this gender. Both MS patients and healthy control
subjects were of average adult age and were similar. The groups were therefore considered comparable.
The time since MS onset in the overall group (male and female) was (mean (standard deviation)): 15.28
(11.17) years. In males it was 15.70 (15.14) years, and in females it was 15.15 (9.97) years. There were
no significant differences in the distribution or central trend (means: p = 0.893, medians: p = 0.686),
nor in variance (p = 0.079). The EDSS score was 1.55 (0.57). Overall, 20% of the patients were not
receiving treatment, 39% were being treated with interferons, and 33% were being treated with immune
modulators (principally fingolimod).
Calculating the discriminant capacity of all the variables available in the database (Table 2), it was
confirmed that the best results in the classifier (highest MCC value) were obtained by considering the
first 3 variables with the highest AUC values as elements of the feature vector, namely, AUCGCL++_Total
= 0.879, AUCETDRS_IN_Retina = 0.859, and AUCETDRS_ON_Retina = 0.849.
Table 3 shows the values of the three variables used to classify the control group and the patients
(GCL++_Total, ETDRS_IN_Retina, ETDRS_ON_Retina), as well as the results of comparing the
distributions, variances, means, and medians.
The values of the three variables were higher in the control subjects than in the MS patients, and
there are significant differences in the distribution, variance, means, and medians (Table 3). Figure 3a–c
shows, in detail, the distribution of the three variables in the control subjects and MS patients. The
values in the following subgroups are also shown: C_M: Controls_Male; C_F: Controls_Female; MS_M:
MS_Male; MS_F: MS_Female. In both the control group and the MS patient group, the combined
GCL++_Total and ETDRS_ON_Retina variables were higher in females than in males.
Figure 3d–f shows the variation with age in the three variables analysed. Of the 12 situations shown
in the figures, in our database, there was only a significant correlation with age in the ETDRS_IN_Retina
variable (r = 0.414, p = 0.014) in the Controls_Female subgroup (Figure 3e).
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Table 1. Comparison of subject ages.
Controls
(n = 48)
MS
(n = 48)
Test to Compare
Distributions
Test to Compare
Variances
Test to Compare
Means
Test to Compare
Medians
AUC
(n = 96)
AUCM
(n = 24)
AUCF
(n = 72)
GCL++_Total
(µm) 151.65 (10.28) 130.91 (16.63)
K-S = 3.162,
p = 0.000
F = 0.381,
p = 0.0009
t = 7.759,
p = 4.43 × 10−7
not assuming
equal variances
W = 326.0,
p = 3.27 × 10−11 0.879 0.750 0.934
ETDRS_IN_Retina
(µm) 317.52 (11.35) 291.28 (30.71)
K-S = 3.102,
p = 8.801 × 10−9
F = 0.136,
p = 1.29 × 10−10
t = 5.937,
p = 6.93 × 10−7
not assuming
equal variances
W = 379.0,
p = 3.20 × 10−10 0.859 0.845 0.853
ETDRS_ON_Retina
(µm) 291.72 (11.28) 270.62 (17.96)
K-S = 3.101,
p = 8.795 × 10−9
F = 0.394,
p = 0.001
t = 7.272,
p = 0.000
not assuming
equal variances
W = 406.5,
p = 1.00 × 10−9 0.849 0.821 0.859
MS: Multiple sclerosis; SD: Standard deviation; C: Control; vs: Versus; n: Number of subjects; K–S: Kolmogorov—Smirnov statistic, p: significance statistics; F: Fisher–Snedecor; t: Student’s
t test; W: Mann–Whitney Wilcoxon.
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Table 2. Operator characteristic curve (AUC) values obtained in the study.
Area Retina Choroid RNFL GCL+ GCL++
ETDRS
Inner superior (IS) 0.818 0.570 – – –
Inner nasal (IN) 0.859 0.520 – – –
Inner inferior (II) 0.836 0.509 – – –
Inner temporal (IT) 0.812 0.512 – – –
Outer superior (OS) 0.755 0.541 – – –
Outer nasal (ON) 0.849 0.501 – – –
Outer inferior (OI) 0.751 0.512 – – –
Outer temporal (OT) 0.712 0.520 – – –
TSNIT
Quadrants
Temporal (T) 0.805 0.515 0.656 0.82 0.772
Superior (S) 0.831 0.516 0.832 0.626 0.805
Nasal (N) 0.733 0.507 0.68 0.685 0.724
Inferior (I) 0.823 0.52 0.766 0.668 0.805
Sectors
Temporal (T) 0.805 0.515 0.656 0.82 0.772
Superotemporal (ST) 0.762 0.511 0.742 0.624 0.768
Superonasal (SN) 0.829 0.502 0.82 0.605 0.829
Nasal (N) 0.753 0.501 0.704 0.685 0.745
Inferonasal (IN) 0.769 0.509 0.692 0.679 0.737
Inferotemporal (IT) 0.770 0.523 0.738 0.596 0.764
Total 0.835 0.517 0.809 0.76 0.879
ETDRS: Early treatment diabetic retinopathy study; TSNIT: Temporal-superior-nasal-inferior-temporal; RNFL:
Retina nerve fibre layer; GCL+ and GCL++: Ganglion cell layers.
Table 3. Values of the variables used in the feature vector.
Controls
(n = 48)
MS
(n = 48)
Test to
Compare
Distributions
Test to
Compare
Variances
Test to
Compare
Means
Test to
Compare
Medians
AUC
(n = 96)
AUCM
(n = 24)
AUCF
(n = 72)
GCL++_Total
(µm)
151.65
(10.28)
130.91
(16.63)
K-S = 3.162,
p = 0.000
F = 0.381,
p = 0.0009
T = 7.759,
p = 4.43 × 10−7
not assuming
equal variances
W = 326.0,
p = 3.27 × 10−11 0.879 0.750 0.934
ETDRS_IN_Retina
(µm)
317.52
(11.35)
291.28
(30.71)
K-S = 3.102,
p = 8.801 × 10−9
F = 0.136,
p = 1.29 × 10−10
t = 5.937,
p = 6.93 × 10−7
not assuming
equal variances
W = 379.0,
p = 3.20 × 10−10 0.859 0.845 0.853
ETDRS_ON_Retina
(µm)
291.72
(11.28)
270.62
(17.96)
K-S = 3.101,
p = 8.795 × 10−9
F = 0.394,
p = 0.001
t = 7.272,
p = 0.000
not assuming
equal variances
W = 406.5,
p = 1.00 × 10−9 0.849 0.821 0.859
MS: Multiple sclerosis; n: Number of subjects; K–S: Kolmogorov–Smirnov statistic, p: Significance statistics; F:
Fisher–Snedecor; t: Student’s t test; W: Mann–Whitney Wilcoxon; AUCM: Area under the curve for males; AUCF:
Area under the curve for females; GCL++_Total: Global GCL++ thickness evaluated at the peripapillary area
between the inner limiting membrane and the inner nuclear layer boundaries; ETDRS_IN_Retina: Macular retina
thickness in the nasal quadrant of the inner ring; ETDRS_ON_Retina: Macular retina thickness in the nasal quadrant
of the outer ring; µm: Micrometres.
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Figure 3. Study of the classifier input variables. (a) GCL++_Total according to subjects subtypes.
(b) ETDRS_IN_Retina according to subjects subtypes. (c) ETDRS_ON_Retina according to subjects
subtypes. (d) GCL++_Total according to age. (e) ETDRS_IN_Retina according to age. (f)
ETDRS_ON_Retina according to age. (g) GCL++_Total according to yearsillness. (h) ETDRS_IN_Retina
according to yearsillness. (i) ETDRS_ON_Retina according to yearsillness. C_M: Controls_Male;
C_F: Controls_Female; MS_M: MS_Male; MS_F: MS_Female; GCL++_Total: Global GCL++ thickness
evaluated at the peripapillary area between the inner limiting membrane and the inner nuclear layer
boundaries; ETDRS_IN_Retina: Macular retina thickness in the nasal quadrant of the inner ring;
ETDRS_ON_Retina: Macular retina thickness in the nasal quadrant of the outer ring.
The GCL++_Total variable decreases with the years of disease in both males and females,
although, in our case, not significantly (pMALES = 0.57, pFEMALES = 0.43), and mostly affecting males.
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The intercepts of the regression were 130.33 and 134.24 for males and females, respectively, while the
slopes were −0.32 and −0.23, respectively (Figure 3g).
The variation in the variable ETDRS_IN_Retina (Figure 3h) with years of disease was negative in
males (slopeMALES = −0.34) and positive in females (slopeFEMALES = 0.27), though, in our case, not
significantly (pMALES = 0.52, pFEMALES = 0.67). The variable ETDRS_ON_Retina decreased in both
sexes, though, again, not significantly (pMALES = 0.58, pFEMALE = 0.78), with the variation being more
pronounced in males (slopeMALES = −0.26, slopeFEMALES = −0.08, Figure 3i).
In the healthy subjects, we observed a significant positive correlation between ETDRS_IN_Retina vs.
ETDRS_ON_Retina (r = 0.674, p = 0.000) and ETDRS_ON_Retina vs. GCL++_Total (r = 0.581, p = 0.000,
Figure 4a). In patients, the strength of these correlations increases (Figure 4b): ETDRS_IN_Retina
vs. ETDRS_ON_Retina (r = 0.781, p = 0.000) and ETDRS_ON_Retina vs. GCL++_Total (r = 0.769,
p = 0.000). In addition, the correlation between ETDRS_IN_Retina vs. GCL++_Total (r = 0.704,
p = 0.000) is significant. Our results suggest that the thickness of the outer and inner nasal retina
correlate with the total GCL++ thickness, especially in patients with MS without previous episodes of
ON and, therefore, it can be assumed that by analysing the thickness of the nasal sector of the retina
(ETDRS protocol) it is possible to ascertain the thickness of the peripapillary GCL++ layer. This can be
useful if OCT devices with segmentation capability are not available, since even analysing the inner
nasal retina with normal OCT devices provides an idea of how the GCL++ layer is behaving.
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MS patients. GCL++_Total: Global GCL++ thickness evaluated at the peripapillary area; 
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3.1. Automatic Classifier 
Classification was performed by taking the three variables as the inputs and the subject status 
(control, MS) as the output, using a SVM with a Gaussian quadratic kernel. The K-fold method (K = 
1) was used, with a cross-validation with a leave-one-out procedure. 
Table 4. Confusion matrix obtained with the Gaussian SVM. 
 
Predicted Class (Males and Females) Predicted Class (Males) Predicted Class (Females) 
Controls MS Controls MS Controls MS 
True 
Class 
Controls 44 4 14 0 30 4 
MS 5 43 3 7 3 35 
MS: Multiple sclerosis; SVM: Support vector machine. 
l ti coefficients betwe n the age and OCT vari bles. (a) In control subjects. (b) In MS
patients. GCL++_Total: Global GCL++ thickness evaluat d at the peripapillary area; ETDRS_IN_Retina:
Macular retina thickness in the nasal quadra t of the inn r ring; ETDRS_ON_Retina: Macular retina
thickness in th nasal quadrant of the outer ring.
Automatic Classifier
Classification was performed by taking the three variables as the inputs and the subject status
(control, MS) as the output, using a SVM with a Gaussian quadratic kernel. The K-fold method (K = 1)
was used, with a cross-validation with a leave-one-out procedure.
Table 4 shows the confusion matrix obtained. The following values define the characteristics of
this matrix: MCC = 0.81, sensitivity = 0.89, specificity = 0.92 and accuracy = 0.91, with an area under the
ROC curve of AUCCLASSIFIER = 0.97 (Figure 5a). Only the males in the sample obtain AUCCLASSIFIER_M
= 0.92 (n = 24) (Figure 5b), while only the females obtains AUCCLASSIFIER_F = 0.97 (n = 72) (Figure 5c).
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Table 4. Confusion matrix obtained with the Gaussian SVM.
Predicted Class (Males and Females) Predicted Class (Males) Predicted Class (Females)
Controls MS Controls MS Controls MS
True Class Controls 44 4 14 0 30 4
MS 5 43 3 7 3 35
MS: Multiple sclerosis; SVM: Support vector machine.
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4. Discussion
In the latest revision to the McDonald criteria [31] the evidence on which to recommend OCT
as a definitive biomarker in fulfilling dissemination in space or in time in support of MS diagnosis is
considered insufficient, so finding novel parameters to increase sensitivity and specificity in terms of
MS is a high priority [32].
The objective of this paper has been to evaluate the MS diagnostic capability of applying
machine-learning techniques to SS-OCT data. It has demonstrated that it is possible to distinguish
between MS patients and healthy subjects using SVM and it is possible to do so with a high degree of
sensitivity and specificity.
The applications of machine-learning techniques have demonstrated their advantages in
MRI-based MS diagnosis. For example, a pattern recognition technique was used in [33] to learn a
discriminant function, obtaining a sensitivity of 0.82 and a specificity of 0.86, so as to distinguish
between MS patients and control subjects using functional MRI (fMRI). In [23], SVMs were used as
classifiers (with diffusion tensor imaging—DTI and fMRI data input) between control subjects and
relapsing-remitting MS patients, obtaining an accuracy of 89% ± 2%.
The analysis of OCT data for use in diagnosis of MS is an active line of research [16,20,34–36].
In a previous paper [37], the authors used a SD-OCT device to take measurements of the RNFL of
106 patients with MS (29% with previous ON) and 115 control subjects. The 768 points registered during
circular peripapillary scan acquisition were grouped to obtain 24 uniformly divided locations (15◦ per
location) that formed the feature vector of a multilayer perceptron trained by the back-propagation
algorithm. Here, the area under the ROC curve of the classification was 0.945. The novel features of
this paper were that the authors studied patients without ON, the measurements were obtained with
more sensitive equipment (SS-OCT), the thickness of the GCL was evaluated at peripapillary level, the
total retinal thicknesses were evaluated at a macular level, a study of the discriminant capacity of the
measurements obtained was conducted to reduce the feature vector to 3 dimensions, and a SVM was
used as classifier.
In the initial stages of the study, the authors analysed the variables obtained from SS-OCT
that showed the greatest capacity to discriminate between the control subjects and MS patients:
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GCL++_Total (global GCL++ thickness evaluated at the peripapillary area), ETDRS_IN_Retina
(macular retina thickness in the nasal quadrant of the inner ring), and ETDRS_ON_Retina (macular
retina thickness in the nasal quadrant of the outer ring).
It is known that retinal layer thickness decreases in humans from the age of 40 onwards. Our
results show that when analysing neuroretinal thickness by sex, healthy males suffer an expected
loss of inner and outer nasal retinal thickness with age. In contrast, in healthy females, there is an
increase in thickness with age, which may be associated with the macular changes and age-associated
degeneration produced in this part of the retina, resulting in the appearance of drusen and cellular
waste and the accumulation of liquid occurring more frequently in females [38].
In MS patients, males suffered a more pronounced loss with age than females, which would
demonstrate greater neurodegenerative damage, an observation that concurs with those of other authors
who have found that RRMS is generally more aggressive in males and that male relapse-onset patients
accumulate disability faster than female patients [39,40]. MS is at least two to three times more common
in females than in males, suggesting that hormones may also play a significant role in determining
susceptibility to MS. There is increasing evidence that oestrogen may impact neuroprotection. Grey
matter atrophy is an important correlate to clinical disability in MS. In MS animal models, mice treated
with the oestrogen receptor (ER)-α ligand or ER-β ligand showed preservation of cerebellar grey matter
and Purkinje cells in MRI and histopathological studies [41].
Males with MS showed a tendency towards greater loss in peripapillary GCL++ in the outer
retinal sector and, finally, in the inner retinal sector, exhibiting a pattern of topographic and sequential
anterograde degeneration corresponding to the papillomacular bundle. In addition, a direct correlation
of statistical significance was demonstrated in MS patients between the GCL++ values and those of
the outer nasal retina (strong) (r = 0.769, p = 0.000) and the inner nasal retina (moderate) (r = 0.704,
p = 0.000).
This loss is reflected in the anterograde degeneration, producing a reduction in average thickness
in the macular area. Consequently, it can be deduced that in its early stages, MS manifests principally
in the papillomacular bundle.
In addition, females with MS exhibited an upward trend in peripapillary GCL++ thickness. This
may have been a reflection of increased immune infiltration by anterograde axonal spread from the
brain, as immune diseases such as MS are known to have a greater incidence in females [42,43].
In regard to the years of disease, similar findings have been made. Males present a greater
tendency to lose thickness than females, this being mainly evident in the inner retina in the form of
greater loss of thickness when compared with females. This suggests more advanced anterograde
degeneration in males after the same number of years of disease progression. This more obvious
difference in the inner retina may be due to the combination of a female protective role as well as to
alterations in the pigment epithelium of the retina and the macular outer retina associated with age.
Conversely, it was also observed that in the variables in which males suffered a more pronounced
loss of thickness than females, the males presented greater thicknesses at earlier ages. In this regard,
volumetric brain analyses recorded higher measurements in young/adolescent males, with lower
measurements at later ages [44]. This suggests that neuroretinal loss is greater when the initial thickness
is greater, as suggested in relation to other neurodegenerative diseases, such as glaucoma [45].
In addition, MS patients of both sexes presented lower thicknesses in the 3 most discriminant
variables from early ages when compared with healthy subjects, suggesting that the development of
the disease could be detected by minor neuroretinal quantification from childhood.
The values recorded in our study in the variables that comprise the feature vector of the classifier
are in general agreement with the findings of other similar papers. In [46], the authors observed with
SD-OCT that a decrease in peripapillary RNFL thickness was identified in the temporal quadrant
(56.6 µm vs. 67.8 µm), mean macular thickness diminished (280 vs. 287 µm, p < 0.05), and there was a
moderate and statistically significant direct correlation between RNFL and mean macular thickness
(r = 0.69, p < 0.01) in individuals with MS without previous ON (p < 0.05). Petzold et al. [19] analysed
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papers evaluating SD-OCT. In total, 15 studies (3154 eyes) have been conducted on patients without
ON, obtaining an estimated peripapillary thickness loss in MS patients compared with control subjects
of 7.08 µm with a 95% CI (8.65 to 5.52) and finding that the peripapillary RNFL and macular GCIPL are
the most affected layers. Our findings with an SS-OCT device, which is more powerful and achieves
greater penetration of the layers, are similar. The ability of the SS-OCT to generate thousands of cuts
quickly increases the resolution of the image and, therefore, it is more sensitive to the detection of very
subtle or early changes. Although this loss of 7.08 µm will naturally depend on the number of years
that the patient has had the disease and the aggressiveness of it (e.g., patients with progressive forms
present greater loss of peripapillary thickness), this paper endeavours to identify the utility of the OCT
thickness variables in the early diagnosis of MS without previous ON, even when that 7-micron loss
has not yet occurred. It is in this case that SVMs can optimize certain specific variables’ capacity to
discriminate between healthy subjects and recent patients.
In [22], it was concluded, using SS-OCT technology, that in MS patients without ON episodes,
significant macular thinning was observed in all ETDRS areas in MS patients, and peripapillary
GCL++ measurements were found to be reduced in all sectors (p < 0.001) except the nasal quadrant
(p > 0.05). In this study, we have demonstrated that the most appropriate variable for optimizing
the MCC parameter is GCL++_Total (AUCGCL++_Total = 0.879). Although GCL+ is the layer that has
been shown to offer most specific value for measuring neurodegeneration in MS [21,47], our results
found GCL++ to be more discriminatory. This may be a consequence of the fact that obtaining this
variable using OCT also obtains RNFL thickness, which, as discussed above, has proven to reflect the
neurodegenerative process in MS disease to a significant extent. In addition, after a prior evaluation
using the AUC, the authors found that the best macular results in the classification were obtained in the
outer and inner ETDRS nasal sectors (AUCETDRS_IN_Retina = 0.859, AUCETDRS_ON_Retina = 0.849), which
correspond to the papillomacular bundle, and were also correlated in strength, showing a pattern of
anterograde neurodegeneration.
There are several reasons why, in this paper, the layers indicated in [19,22] have not been used
as a feature vector for the SVM classifier. The meta-analysis conducted by Petzold et al. refers to
papers that used SD-OCT devices, and the measurements of retinal layers are different in terms of
the Fourier-domain and swept-source technologies [48,49]. In relation to [22], it should be noted that
the ultimate objective of this paper has been to obtain the best MCC parameter for classification. For
that reason, the feature vector variables selected for the classifier are the combination that maximizes
this parameter.
From the point of view of the practical application of the proposed method, the retina measurements
were recorded using an SS-OCT device that, in a single take, using the 3D wide protocol, analyses a
12 × 9 mm area of the posterior pole, including the macula (ETDRS scan) and optic nerve head (TSNIT
scan). The feature vector is made up of data from the macula and the optic nerve and, therefore, if the
positive results produced by the classifier are confirmed in a more extensive study, it would be viable
to implement the method set out in this paper in OCT software and receive a proposed diagnosis in
real time.
OCT has been shown to be a useful tool for diagnosing and monitoring progressive neuroretinal
loss in neurodegenerative pathologies such as Alzheimer’s or Parkinson’s disease, as well as
for detecting dynamic changes in neuroinflammatory diseases such as MS. Structural variables
obtained using OCT help differential diagnosis in disorders that overlap clinically with MS, such
as neuromyelitis optic spectrum disorders (NMOSD), myelin-oligodendrocyte-glycoprotein (MOG)
seropositive autoimmunity or Susac syndrome (SuS). However, definitive OCT biomarkers for
diagnosing MS in early-onset or difficult cases, or for differentiating between the various MS-like
entities, have not yet been found [32]. This study has made it possible to detect the 3 most discriminant
variables for use in an early-onset MS SVM classifier that could serve as differential parameters in
MS-like pathologies or in difficult cases where MRI is not effective.
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5. Conclusions
Currently, MS diagnosis is based on clinical and standard neuroimaging symptoms defined by
the updated McDonald criteria [31]. However, it is accepted that the information provided by OCT
plays a relevant role in ascertaining the degree of axonal damage. Definitive MS diagnosis based on
the fulfilment of the McDonald criteria can take many years from the appearance of the first symptoms.
Accelerating diagnosis has many benefits for patients, as there are several new disease-modifying
treatments (alemtuzumab, cladribine, or ocrelizumab) that, if administered at an early stage, would
help halt the progression of MS and the associated neural damage.
In this paper, we have demonstrated that it is possible to classify control subjects and MS patients
without previous ON by applying machine-learning techniques to study structural neurodegeneration
in the retina. Our findings suggest that including OCT in MS diagnostic criteria could help expedite
definitive diagnosis.
This study has several limitations that can be overcome in the future. Firstly, it would be desirable
to have a database of patients and control subjects from various centres. Secondly, the possible
correlations between the OCT variables analysed and the MRI results were not analysed. If the
findings were corroborated, the OCT technique would be a more accessible and cost-efficient biomarker.
It would also be beneficial to replicate the study using variables obtained with SD-OCT devices, which
are those which are currently used in clinical practice.
In addition, and as future lines of research, applying the methods developed for the structural
analysis of the retina in other diseases (e.g., Alzheimer’s or Parkinson’s disease), analysing other
layers of the retina, and looking for areas with maximum discriminant capacity that do not follow the
morphology defined by the ETDRS or TSNIT grids [50] are suggested.
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